CSIMarket
 


Kempharm Inc  (KMPH)
Other Ticker:  
 
 

Kempharm Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics



KMPH Asset Turnover Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Asset Change 10.08 % -10.48 % 39 % 1086.02 % 1124.44 %
Y / Y Revenue Change 46.26 % -89.15 % -67.28 % 9.13 % 2.08 %
Asset Turnover Ratio (TTM) 0.08 0.08 0.15 0.23 0.3
Total Ranking # 2269 # 2375 # 2360 # 1871 # 1893
Seq. Asset Change 21.53 % -1.15 % -5.44 % -3.09 % -1.16 %
Seq. Revenue Change 121.08 % -67.21 % 53.56 % 31.4 % -83.61 %


Asset Turnover Ratio Comment
Kempharm Inc's asset turnover ratio remained unchanged at 0.08

Within Healthcare sector 394 other companies have achieved higher asset turnover ratio than Kempharm Inc. While asset turnover ratio remained unchanged compare to previous quarter at no. .

What is Asset Turnover Ratio?
What is Kempharm Inc Market Share?

Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 140
Healthcare Sector # 395
Overall Market # 2269

Asset Turnover Ratio Statistics
High Average Low
1.96 0.64 0.08
(Jun 30 2020)   (Jun 30 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Sutro Biopharma Inc   0.20 $ 69.794  Millions$ 357.851  Millions
Adaptive Biotechnologies Corporation  0.19 $ 168.040  Millions$ 868.095  Millions
Sonendo Inc   0.19 $ 21.539  Millions$ 111.306  Millions
Regen Biopharma Inc   0.19 $ 0.126  Millions$ 0.654  Millions
Personalis Inc   0.19 $ 69.007  Millions$ 363.254  Millions
Pieris Pharmaceuticals Inc   0.19 $ 24.113  Millions$ 128.693  Millions
Bionik Laboratories Corp   0.18 $ 1.151  Millions$ 6.243  Millions
Rvl Pharmaceuticals Plc  0.18 $ 26.208  Millions$ 142.291  Millions
Morphic Holding inc   0.18 $ 74.230  Millions$ 406.605  Millions
Revance Therapeutics Inc   0.18 $ 108.594  Millions$ 611.046  Millions
Eyepoint Pharmaceuticals Inc   0.18 $ 42.415  Millions$ 240.463  Millions
Evoke Pharma Inc   0.17 $ 2.073  Millions$ 11.854  Millions
Fibrogen Inc   0.17 $ 122.911  Millions$ 703.845  Millions
Sangamo Therapeutics Inc   0.17 $ 112.055  Millions$ 646.818  Millions
Atara Biotherapeutics Inc   0.17 $ 70.900  Millions$ 417.461  Millions
Mirum Pharmaceuticals Inc   0.17 $ 52.294  Millions$ 308.595  Millions
Cytokinetics Incorporated  0.17 $ 148.231  Millions$ 886.313  Millions
Arbutus Biopharma Corp  0.17 $ 35.980  Millions$ 215.250  Millions
Delcath Systems Inc   0.16 $ 4.190  Millions$ 25.433  Millions
Inspiremd Inc   0.16 $ 5.551  Millions$ 33.928  Millions
Beigene Ltd   0.16 $ 1,249.805  Millions$ 7,692.889  Millions
Yumanity Therapeutics Inc   0.16 $ 4.845  Millions$ 29.885  Millions
Ngm Biopharmaceuticals Inc   0.16 $ 58.111  Millions$ 358.849  Millions
Exicure Inc   0.16 $ 6.806  Millions$ 43.165  Millions
Biocorrx Inc   0.16 $ 0.145  Millions$ 0.918  Millions
Omnia Wellness Inc  0.15 $ 0.353  Millions$ 2.288  Millions
Isoray Inc   0.15 $ 9.948  Millions$ 65.086  Millions
Alector Inc   0.15 $ 133.171  Millions$ 873.956  Millions
Meiragtx Holdings Plc  0.15 $ 44.106  Millions$ 290.433  Millions
Lifestance Health Group Inc   0.15 $ 295.798  Millions$ 1,958.459  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GALT's Profile

Stock Price

GALT's Financials

Business Description

Fundamentals

Charts & Quotes

GALT's News

Suppliers

GALT's Competitors

Customers & Markets

Economic Indicators

GALT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071